Enhanced stability of polyacrylate-coated magnetite nanoparticles in biorelevant media (original) (raw)
Related papers
Materials Science and Engineering: C, 2017
A novel multifunctional nanosystem formed by magnetite nanoparticles coated with pH-responsive poly(aspartic acid) hydrogel was developed. Magnetite nanoparticles (Fe 3 O 4) have been intensively investigated for biomedical applications due to their magnetic properties and dimensions similar to the biostructures. Poly(aspartic acid) is a water-soluble, biodegradable and biocompatible polymer, which features makes it a potential candidate for biomedical applications. The nanoparticles surface modification was carried out by crosslinking polysuccinimide on the magnetite nanoparticles surface and hydrolyzing the succinimide units in mild alkaline medium to obtain the magnetic poly(aspartic acid) hydrogel. The surface modification in each step was confirmed by DRIFTS, TEM and zeta potential measurements. The hydrodynamic diameter of the nanosystems decreases as the pH value decreases. The nanosystems showed high colloidal stability in water and no cytotoxicity was detected, which make these nanosystems suitable for biomedical applications.
2012
Magnetite nanoparticles (MNPs) coated with poly(acrylic acid-co-maleic acid) polyelectrolyte (PAM) have been prepared with the aim of improving colloidal stability of core−shell nanoparticles for biomedical applications and enhancing the durability of the coating shells. FTIR-ATR measurements reveal two types of interaction of PAM with MNPs: hydrogen bonding and inner-sphere metal−carboxylate complex formation. The mechanism of the latter is ligand exchange between uncharged −OH groups of the surface and −COO − anionic moieties of the polyelectrolyte as revealed by adsorption and electrokinetic experiments. The aqueous dispersion of PAM@MNP particles (magnetic fluids − MFs) tolerates physiological salt concentration at composition corresponding to the plateau of the high-affinity adsorption isotherm. The plateau is reached at small amount of added PAM and at low concentration of nonadsorbed PAM, making PAM highly efficient for coating MNPs. The adsorbed PAM layer is not desorbed during dilution. The performance of the PAM shell is superior to that of poly(acrylic acid) (PAA), often used in biocompatible MFs. This is explained by the different adsorption mechanisms; metal−carboxylate cannot form in the case of PAA. Molecularlevel understanding of the protective shell formation on MNPs presented here improves fundamentally the colloidal techniques used in core−shell nanoparticle production for nanotechnology applications.
Cellular interactions of lauric acid and dextran-coated magnetite nanoparticles
2007
In vitro cytocompatibility and cellular interactions of lauric acid and dextran-coated magnetite nanoparticles were evaluated with two different cell lines (mouse fibroblast and human cervical carcinoma). Lauric acid-coated magnetite nanoparticles were less cytocompatible than dextran-coated magnetite nanoparticles and cellular uptake of lauric acid-coated magnetic nanoparticles was more than that of dextran-coated magnetite nanoparticles. Lesser cytocompatibility and higher uptake of lauric acid-coated magnetite nanoparticles as compared to dextran-coated magnetic nanoparticles may be due to different cellular interactions by coating material. Thus, coating plays an important role in modulation of biocompatibility and cellular interaction of magnetic nanoparticles.
Effects of AC magnetic field and carboxymethyldextran-coated magnetite nanoparticles on mice …
Journal of Magnetism and Magnetic Materials, 2005
A portable apparatus was developed to perform magnetohyperthermia (MHT) assays. In order to investigate its efficiency on cell lysis, biological effects of the AC magnetic field exposure after carboxymethyldextran-coated magnetite-nanoparticles (CMDC) treatment were investigated. Phagocyte capacity, cell viability, and morphology data evidenced that the CMDC sample and the apparatus are useful to further investigate MHT in cancer therapy.
Toxicology Reports, 2021
Recent advances in the use of magnetite nanoparticles for biomedical applications have led to special attention to these nanoparticles. The unique properties of magnetite nanoparticles such as superparamagnetism, low toxicity, and the ability to bond with biological molecules, are suitable for drug delivery, diagnostic methods and therapeutic approaches. The aim of this study was to synthesize magnetite nanoparticles with different biocompatible coatings and investigate their cytotoxicity. Magnetite nanoparticles were synthesized by co-precipitation method and the cytotoxicity of these nanoparticles was investigated with Hepatoma G2 cell using the MTT assay. Treated cells, did not showed any evident cell cycle arrest. The Fourier Transmission Infrared (FTIR) spectroscopy, X-ray powder Diffraction (XRD), Transmission Electron Microscopy (TEM) were evaluated. The results of XRD showed the coated magnetite nanoparticles were 10− 12 nm and this size also achieved with TEM images. Synthesized magnetite nanoparticles with SiO 2 and oleic acid coatings had lower cytotoxicity than other coatings.
Magnetic resonance of polyaspartic acid-coated magnetite nanoparticles administered in mice
IEEE Transactions on Magnetics, 2000
Magnetic resonance (MR) was used in the biodistribution investigation of magnetic nanoparticles (MNPs) surface-coated with polyaspartic acid (PAMF), developed as a biocompatible magnetic fluid (BMF) sample. The data allowed us to obtain the kinetic parameters for MNP disposition from the blood and its uptake by the liver, spleen, and lungs. Light microscopy confirmed the MR results. Genetic and toxicity tests showed that the PAMF is reasonable biocompatible. The PAMF sample presented peculiar biodistribution patterns and may be considered as a potential precursor of anticancer drugs.
International Journal of Molecular Sciences
Biopolymer coated magnetite nanoparticles (MNPs) are suitable to fabricate biocompatible magnetic fluid (MF). Their comprehensive characterization, however, is a necessary step to assess whether bioapplications are feasible before expensive in vitro and in vivo tests. The MNPs were prepared by co-precipitation, and after careful purification, they were coated by chondroitin-sulfate-A (CSA). CSA exhibits high affinity adsorption to MNPs (H-type isotherm). We could only make stable MF of CSA coated MNPs (CSA@MNPs) under accurate conditions. The CSA@MNP was characterized by TEM (size ~10 nm) and VSM (saturation magnetization ~57 emu/g). Inner-sphere metal–carboxylate complex formation between CSA and MNP was proved by FTIR-ATR and XPS. Electrophoresis and DLS measurements show that the CSA@MNPs at CSA-loading > 0.2 mmol/g were stable at pH > 4. The salt tolerance of the product improved up to ~0.5 M NaCl at pH~6.3. Under favorable redox conditions, no iron leaching from the magne...
Surface modification of magnetite nanoparticles for biomedical applications
Journal of Magnetism and Magnetic Materials, 2009
The preparation of magnetite nanoparticles with narrow size distributions using poly(ethylene glycol) (PEG-COOH) or carboxymethyl dextran (CMDx) chains covalently attached to the particle surface using carbodiimide chemistry is described. Particles were synthesized by thermal decomposition and modified with 3-aminopropyl trimethoxysilane (APS) to render particles with reactive amine groups (-NH 2 ) on their surface. Amines were then reacted with carboxyl groups in PEG-COOH or CMDx using carbodiimide chemistry in water. The size and stability of the functionalized magnetic nanoparticles was studied as a function of pH and ionic strength using dynamic light scattering and zeta potential measurements.
Despite the large efforts to prepare super paramagnetic iron oxide nanoparticles (MNPs) for biomedical applications, the number of FDA or EMA approved formulations is few. It is not known commonly that the approved formulations in many instances have already been withdrawn or discontinued by the producers; at present, hardly any approved formulations are produced and marketed. Literature survey reveals that there is a lack for a commonly accepted physicochemical practice in designing and qualifying formulations before they enter in vitro and in vivo biological testing. Such a standard procedure would exclude inadequate formulations from clinical trials thus improving their outcome. Here we